chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lightheadedness, dizziness, near syncope, vision darkened. All started within 10 minutes of injection, resolved within 1 hour. rash torso and neck/scalp/face started less than hour later, lasting 2-3 days.
This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported that a currently 67-year-old male patient of an unspecified ethnicity received PREVNAR 13 at the age of 63 years, via an unspecified route of administration in Jun2014 at single dose for immunization. Medical history included type 2 diabetes mellitus. The patient's concomitant medications were not reported. It was reported that PTSD was diagnosed after this whole ordeal [Pneumococcal Pneumonia in JUN2014], and after this sickness, patient started to not want to do anything, kept people at a distance and ended up getting on medication for anxiety and depression. Patient also talk with a doctor one a month or so to keep him focused and positive. He was a type 2 diabetic now as well and have sleep apnea. During this whole process he lost 26 pounds. Consumer described having pneumococcal 13-val conj vac (dipht crm197 protein) shot in Jun2014 and again in Oct2016. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.
After the 1st dose, by the afternoon I was just tired and my arm was a little pain and it wasn't bad. The nest day I woke up with a headache for a month. It was very unusual for me to get headaches because I never had it. Cholesterol went up higher. Sometimes I get headaches now which rarely happened before the 1st dose.
Information has been received from a physician assistant concerning unspecified patients. The patients' concomitant medications, pertinent medical history, and drug reactions and allergies have not been provided. On unspecified dates these patients were administered improperly stored M-M-R II (rHA) (lot # M004063, expired date 25-JAN-2018, and lot # L039613, expired date 08-OCT-2017) (dose and frequency were unknown). No adverse effects reported. M-M-R II was stored at 46.8 F for 4 hours 30 minutes. This is one of several reports received from the same reporter. Additional information has been requested.
Fever d 4-5 post immunizations T 101-103 degrees. Visual hallucinations d 4-5 with and without fever - sleeping and garbe headache d 3-5
Mom returned at 45" after receiving vaccine. C/O she and daughter have numbness in injected arm. Mom states daughter also has pain going up neck. SN suggested ibuprofen, ice - if continues call MD or ER.
Allergic reaction; Tongue felt full; Did not feel well; Puffiness; Trouble swalloing; rash; Swollen glands; Blood pressure high/ changes in blood pressure; Felt faintness; Feeling hot; Fluid accumulation; Turned a dark, pinkish color/ flushed; Changes in heart rate/ heart was racing; A spontaneous report was received from a health care professional concerning a 68-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced allergic reaction/ hypersensitivity, feeling hot, fluid retention, flushing, presyncope, heart rate abnormal, swelling face, tongue felt full/ swollen tongue, hypertension, dysphagia, not feeling well/ malaise, rash, and lymphadenopathy.  The patient's medical history, as provided by the reporter, included anaphylaxis to Keflex, lisinopril and sulfa drugs. Concomitant medications reported included HCTZ, diltiazem, rosuvastatin, isosorbide mono, metoprolol and pepcid.   On 25 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On the same day patient experienced allergic reactions, feeling hot, fluid retention, flushing, presyncope, high blood pressure, swollen glands. On 26 Jan 2021, the patient was taken into the hospital and kept there for 6 hours.  On 29 Jan 2021, the patient still had faintness. Her heart was racing and she did not feel well.  On 04 Feb 2021, her tongue felt full and something did not feel right. The patient's vital signs included blood pressure 190/98 and later 140/80.  Treatment details included Benadryl, EpiPen, Ativan, Solumedrol, steroids, and Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, feeling hot, fluid retention, lymphadenopathy, and rash were considered recovered/resolved on an unknown date. The outcome of the events, flushing, and presyncope, was considered not recovered/not resolved. The outcome of the events, allergic reaction, hypertension, heart rate abnormal, swelling face, swollen tongue, malaise, and dysphagia, was not provided.; Reporter's Comments: This case concerns a 68 Y/O F who had serious unexpected hypersensitivity along with unexpected BP high, heart rate abnormal, presyncope, dysphagia, face swelling, swollen tongue, flushing, feeling hot, malaise, fluid retention, and expected rash, lymphadenopathy.  Event onset the same day as first dose mRNA-1273. Treated with Benadryl, EpiPen, steroids. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
PATIENTS ARM WAS LOCALLY SWOLLEN IMMEDIATELY AFTER THE VACCINATION, A FEW HOURS LATER HER WHOLE ARM WAS SWOLLEN AND UNABLE TO LIFT UP, THE AREA OF THE VACCINATION WAS SORE TO TOUCH, THIS CONTINUED UNTIL THE NEXT MORNING, CURRENT CONDITION IS UNKNOWN
Patient was found unresponsive. Code blue was called. Patient was taken to hospital for evaluation.  Was evaluated at hospital. Labs and vital signs were normal and returned to facility prior to clinic ending.
Confusion; Nausea; Nervous attacks; Shortness of breath; Couldn't sleep at night; Tremors; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (Nervous attacks), DYSPNOEA (Shortness of breath), INSOMNIA (Couldn't sleep at night), TREMOR (Tremors) and CONFUSIONAL STATE (Confusion) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jul-2021, the patient experienced NERVOUSNESS (Nervous attacks), DYSPNOEA (Shortness of breath), INSOMNIA (Couldn't sleep at night), TREMOR (Tremors) and NAUSEA (Nausea). On 11-Aug-2021, the patient experienced CONFUSIONAL STATE (Confusion). At the time of the report, NERVOUSNESS (Nervous attacks), DYSPNOEA (Shortness of breath), INSOMNIA (Couldn't sleep at night), TREMOR (Tremors), CONFUSIONAL STATE (Confusion) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The patient was told to take Benadryl by the pharmacist.
Administered DTAP, IPV and MMR given. Noticed while placing Bandaids on that left arm at site of MMR reddened. Pt complained of nothing being wrong except arms sore from injections. Also noticed few red areas on other arm and chest. Notified MD immediately. Benadryl 15mg given and Prelone ttsp po as ordered by MD.
feeling uneasy; I couldn't get down water; I woke up nauseous; started vomiting violently; diarrhea; This is a spontaneous report from a contactable consumer (patient herself). A 33-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 03Aug2021 18:00 (age at vaccination: 33 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included immune thrombocytopenia (ITP) , splenectomy which was recovered , cerebrovascular accident from Aug2012, gastrectomy from Feb2019, covid-19 prior vaccination. Concomitant medication(s) included cetirizine hydrochloride (ZYRTEC); aspirin (acetylsalicylic acid); esomeprazole magnesium (NEXIUM); risankizumab rzaa (SKYRIZI) and sertraline hydrochloride (ZOLOFT). The patient did not have any other vaccine in four weeks. It was unknown if patient had any known allergies. On 04Aug2021 02:00, the patient woke up nauseous, started vomiting violently approximately 6 to 8 times, diarrhea and couldn't get down water. The patient was prescribed zofran for nausea and it stopped 04Aug around 8pm. I had diarrhea and nausea through 06Aug. On 08Aug2021, the patient was feeling uneasy. Still was feeling uneasy on 08Aug2021. The adverse events resulted in physicians office visit. The patient was not tested for covid post vaccination. The outcome of all the events was recovering with sequalae.   The lot number for the vaccine was not provided and will be requested during follow-up.
Pt seen 2Jun90 for fever diarrhea & cough.Improved slightly prior to admit to hospital had increase in respiration rate & coungh. Pt D/C 24Jun90
Day 1: Fever of 101, fatigue. Duration 12 hours No medication given.   Day  3: intermittent dry cough .  Night terrors (previously she never had these).  Day 4: intermittent dry cough, bloodshot left eye.
Body- Massive body ache, body chills, headache and slight fever Arm- Tender to touch, warm and Pain at injection site.  All of this happens the second day after the vaccination took place.
Arm became increasingly sore at The site throughout the day. Around 1130 last night I got the chills &started to feel achy. I took my temperature there was no fever. Around 330 this morning I woke up feeling much worse with the chills achiness took my temp it was 100.6 took some Motrin. I went back to bed very hard time sleeping because I felt so terrible. Woke up this morning so far no fever but feel achy, still have chills and really fatigued.
Pt developed an urticarial rash that developed on the leg in which the PENTACEL was administered. Then the rash appeared within 5-10 minutes and resolved in 5-10 minutes. Subsequently the legs became very red which was likely possible pt was getting a blood draw for unrelated matter. Then the patients redness resolved but had few remaining red spots.
Arm  sore about 3 days, then at day 9 itching, pain, swelling, and redness of arm muscle at injection site.  Feels like needle sticking in muscle.  Now day 10 and symptoms persist.
Patient is pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant) in a 37-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 29-May-2021. On 27-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant). On 27-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment details were not reported.
Severe shingles on left side. Areas affected: left cheek, left ear, jawline, left side of neck, upper back, top of shoulder, upper chest along collarbone.
arm soreness-so sore I could hardly move it; arm soreness-so sore I could hardly move it; sinus headache off and on; red rash right above naval to bra line; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot, expiry date unknown), via an unspecified route of administration on 11Jan2021 16:30 at a single dose covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient experienced arm soreness- so sore she could hardly move it, but she iced it and now it's getting better, woke up this morning red rash right above naval to bra line- it was almost already gone, sinus headache off and on. The patient did not really feel sick. She was sensitive to medications. Patient was scheduled for 2nd dose on 01Feb2020. The outcome of the event arm soreness-so sore I could hardly move it and red rash right above naval to bra line was recovering, and unknown outcome for the event sinus headache.   Information on the Lot/Batch number has been requested.; Sender's Comments: This is a spontaneous report from a contactable consumer or other non hcp.  A female patient of an unspecified age started to receive bnt162b2 (BNT162B2) , via an unspecified route of administration from 11Jan2021 16:30 to 11Jan2021 16:30 at SINGLE DOSE for   .  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced arm soreness-so sore i could hardly move it (pain in extremity) (non-serious) on an unspecified date with outcome of recovering , arm soreness-so sore i could hardly move it (mobility decreased) (non-serious) on an unspecified date with outcome of recovering , red rash right above naval to bra line (rash erythematous) (non-serious) on 12Jan2021 with outcome of recovering , sinus headache off and on (sinus headache) (non-serious) on an unspecified date with outcome of unknown.  The action taken in response to the event(s) for bnt162b2 was not applicable.  Therapeutic measures were taken as a result of arm soreness-so sore i could hardly move it (pain in extremity), arm soreness-so sore i could hardly move it (mobility decreased).
On the 19th I began feeling something wasn't right. I had a foggy feeling in the head and increased congestion. That morning I had sore throat and heavy flu like symptoms with heavy congestion, headache and phlegm in my throat. I did not want to get out of bed. I used a at home test kit, and it was positive on 12/20/2022. I contacted my PCP, that morning I was not offered any medications for my symptoms. The person in the office called me back with a reference to the local treatment center that was not helpful and 4 and a half hours later they called me back. I decided to go to an urgent care instead and was retested and received a prescribed PAXLOVID. I am finished with the doses, and I tested negative on 12/26/2022. I feel okay.
Headache, Myalgia, Fever, chills, body aches, fatigue, nausea, chest tightness, joint aches, night sweats Narrative:
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2021US159961_OS (RA). A 51 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer- Unknown, Dose number unknown), for COVID-19 immunization. The following information was reported: EMOTIONAL DISORDER (non-serious), outcome "unknown", described as "Emotional for weeks"; DEPRESSION (non-serious), outcome "unknown", described as "Little depression". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient came to our pharmacy and received a tetanus shot on 07/13/17. She showed back up at the pharmacy on 07/17/17 stating that she developed a Urinary tract infection as a result of the shot she got on the previous Thursday. She did not describe her symptoms at all, but she did state that she was in a lot of pain and that she needed to hurry home to take a bath.
Information has been received from a consumer concerning her daughter with no pertinent medical history, drug reactions or allergies who at approximately one year of age was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck). On an unspecified date in approximately the winter of 2004 the patient developed a mild case of chickenpox. There was no concomitant medication. At the time of reporting the patient had recovered on an unspecified date. There were no lab diagnostic studies performed. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
After first dose on 12/30/2020  everything was fine. After 2nd dose of 1/20/2021, knot formed in right wrist in June of 2021. Patient started prednisone for the next full year until present. Numbness, tingling, stiffness persists in right arm, has lost strength in right arm. Persisted from June 2021 until present.
Shot at 12pm. Fever started 6pm. Fever rose to 102.7 at 11pm. Fever returned to normal at 4AM following day. Chills, muscle soarness, headache.  Mild symptoms and nauseous on day 2. Return to normal day 3.
Pt was having fainting like symptoms after he was at the work desk after the flu shot. Patient slightly fainted before he can call for help. Patient woke up and called for help and was having slight sweating. Patient?s breathing was normal and pulse was normal by the time we went there to help. Patient stated he was fine at that point and was checked again in 30 minutes. Patient  have had history of fainting after shots before.
No adverse effects; The patient was vaccinated with improperly stored vaccines.; This spontaneous report was received from a nurse referring to patients of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 05-MAR-2020 15:19, the patient was vaccinated with improperly stored dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL), 0.5 milliliter, intramuscular in the right arm with lot # reported as "9139Z " (strength, frequency, and expiration date were unknown) and with an improperly stored dose of diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid(TDAP) at 15:10, 0.5 milliliter, intramuscular in the left arm with lot # reported as "9139Z " (strength, frequency, and expiration date were unknown) for prophylaxis. The temperarure excursion was no reported for the these vaccines. No adverse effects reported.; Sender's Comments:  US-009507513-2008USA008883: US-009507513-2008USA008876: US-009507513-2008USA008875: US-009507513-2003USA002275: US-009507513-2008USA008877: US-009507513-2008USA008890: US-009507513-2008USA008889: US-009507513-2008USA008885: US-009507513-2008USA008890: US-009507513-2008USA008891: US-009507513-2008USA008892: US-009507513-2008USA008893: US-009507513-2008USA008894: US-009507513-2008USA008896: US-009507513-2008USA008897: US-009507513-2008USA008898: US-009507513-2008USA008899: US-009507513-2008USA008900: US-009507513-2008USA008901: US-009507513-2008USA008902: US-009507513-2008USA008903: US-009507513-2008USA008904: US-009507513-2008USA008906: US-009507513-2008USA008907: US-009507513-2008USA008908: US-009507513-2008USA008909: US-009507513-2008USA008910: US-009507513-2008USA008911: US-009507513-2008USA008912: US-009507513-2008USA008913: US-009507513-2008USA008914: US-009507513-2008USA008915: US-009507513-2008USA008916: US-009507513-2008USA008917: US-009507513-2008USA008918: US-009507513-2008USA008919: US-009507513-2008USA008920: US-009507513-2008USA008921: US-009507513-2008USA008922: US-009507513-2008USA008923: US-009507513-2008USA008924: US-009507513-2008USA008925: US-009507513-2008USA008926: US-009507513-2008USA008927: US-009507513-2008USA008928: US-009507513-2008USA008929: US-009507513-2008USA008930: US-009507513-2008USA008931: US-009507513-2008USA008932: US-009507513-2008USA008933: US-009507513-2008USA008878: US-009507513-2008USA008879: US-009507513-2008USA008880: US-009507513-2008USA008881: US-009507513-2008USA008882: US-009507513-2008USA008884: US-009507513-2008USA008886: US-009507513-2008USA008887: US-009507513-2008USA008888:
After giving the vaccine, patient reported itchy side effects within a few minutes. We gave him a dose of Benadryl with water and monitored him.
Pain at injection site - As Soon as Administered Headache - Sat-Mon - Treatment Ibuprofen Redness & Swelling - Sat-Present Still Mild Fever 101 - Sat-Mon Slight Rash below injection site - Sun-Present Chills Body Aches - Sat-Mon
Pt vaccinated with DTP/OPV developed swollen tongue & sticking out of her mouth. Swelling lasted approx 12 hrs. Her mouth remained open & she would not eat. No difficulty breathing or associated rash. Following day had a fever to 103.4.
I thought that i had picked up the MMR that is what i read on it but it was MMRV  I did not see the varicella on the box when i read it. so the patient was given varicella and extra dose.
Patient went to pain management Dr and Dr believes patient may have had the start of cellulitis from poor circulation, wanted to be cautious and gave patient BACTRIM DS
Pt recivied her 2nd covid 19 vaccine on 3/26. Patient is a 76-year-old female with a past medical history significant for hypertension, depression, hypothyroidism 2nd covid 19 vaccine on 3/26 who presented on 5/18  to the ER with complaints of lightheadedness and nausea that occurred over the weekend and was diagnosed with new onset rapid atrial fibrillation.  She denied chest pain or shortness of breath but noticed intermittent bouts of palpitations.  She went to see her PCP who referred her to the emergency room.  EKG and telemetry  in the emergency room were significant for new onset rapid atrial fib.  She was given diltiazem and admitted to the hospitalist service.  CT of the chest was negative for pulmonary emboli or focal consolidation.  She had no electrolyte derangements she has no history of sleep apnea and no history of obesity.  Her troponin and delta were unremarkable.  She was subsequently admitted to the hospitalist service.  She was treated with metoprolol and amiodarone  along with Eliquis.  She was seen by her cardiologist.  Her recent echocardiogram was normal.  Her TSH was actually elevated at 11.0 so her levothyroxine dose was increased to 175 mcg daily with a TSH in 6 weeks.  At this time patient's rate is much better controlled but she remains in atrial fib.  She will be following up with her cardiologist closely post discharge. She is also complaining of persistent R shoulder pain and weakness since her vaccine. Her shoulder x ray showed arthritic changes. She also c/o the worst headache of her life that lasted a week starting on May 4th. CT head was neg.
CHILLS; FEVER; This spontaneous report received from a vaccine facility concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported. The unspecified Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fever. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and chills was not reported. This report was non-serious.
THE PATIENT WAS HAPPY THAT HE GOT THE 1ST DOSE OF COVID VACCINE. HE DID NOT REPORT ANY ADVERSE REACTION.